ITI with a VWF-stabilised FVIII concentrate in haemophilia a patients with inhibitors and a poor prognosis for ITI success: progress report on octanate in the observational obsiti study

被引：0

作者：

Zozulya, N. ^{[1
]}

Plysch, O. ^{[1
]}

Vdovin, V. ^{[2
]}

Andreeva, T. ^{[3
]}

Svirin, P. ^{[2
]}

Severova, T. ^{[4
]}

Shiller, E. ^{[2
]}

Klimova, N. ^{[5
]}

Benedik-Dolnicar, M. ^{[6
]}

Velasco, F. ^{[7
]}

Campos, M. ^{[8
]}

Bichler, J. ^{[9
]}

Escuriola, C. ^{[10
]}

Kreuz, W. ^{[11
]}

机构：

[1] Moscow Natl Hematol Ctr, Moscow, Russia

[2] Izmailovsky Childrens Hosp, Haematol Ctr, Moscow, Russia

[3] City Haemophilia Treatment Ctr N37, St Petersburg, Russia

[4] State Haematol Sci Ctr RAMS, Moscow, Russia

[5] City Haemophilia Treatment Ctr, City Healthcare Inst, St Petersburg, Russia

[6] Childrens Hosp Clin Ctr, Comprehens Care Ctr, Ljubljana, Slovenia

[7] Hosp Reina Sofia, Serv Hematol, Cordoba, Spain

[8] Hosp Santo Antonio, Oporto, Portugal

[9] Octapharma AG, Lachen, SZ, Switzerland

[10] Johann Wolfgang Goethe Univ Hosp, Haemophilia Comprehens Care Ctr, Frankfurt, Germany

[11] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷

关键词：

Haemophilia A; Inhibitors; ITI success; ObsITI study; Octanate; poor prognosis for ITI; VWF-stabilised FVIII concentrate;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：30 / 31

页数：2

共 18 条

[11] IMPACT OF FACTOR VIII GENE (F8) MUTATION ON IMMUNE TOLERANCE INDUCTION (ITI) OUTCOMES IN HAEMOPHILIA A PATIENTS WITH INHIBITORS IN THE OBSITI STUDY
Pavlova, A.
Escuriola-Ettingshausen, C.
Oldenburg, J.
HAEMOPHILIA, 2020, 26 : 54 - 54
[12] The Octanate® immune tolerance induction experience in haemophilia A patients with inhibitors and poor prognosis:: prospective post-marketing study in progress
Zozulya, N.
Plyushch, O.
Severova, T.
HAEMOPHILIA, 2008, 14 : 51 - 51
[13] The Octanate® immune tolerance induction experience in haemophilia A patients with inhibitors and a poor prognosis:: prospective post-marketing study in progress
Zozulya, N. I. .
Plyushch, O. P.
Severova, T. V.
HAEMOPHILIA, 2008, 14 : 150 - 150
[14] Immune tolerance induction (ITI) according to the Bonn protocol in haemophilia A patients with inhibitors using a plasma-derived VWF-containing factor VIII concentrate: two paediatric case reports
Lohse, J.
Gehrisch, S.
Escuriola-Ettingshausen, C.
Kreuz, W.
Knoefler, R.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1073 - 1074
[15] Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study
Jimenez-Yuste, V.
Oldenburg, J.
Rangarajan, S.
Peiro-Jordan, R.
Santagostino, E.
HAEMOPHILIA, 2016, 22 (06) : 859 - 865
[16] Treatment of Haemophilia a (HA) Patients with Inhibitors: Immune Tolerance Induction with a Single Factor VIII/Von Willebrand Factor Concentrate in an Observational Immune Tolerance Induction Study (ObsITI)
Ettingshausen, C. Escuriola
Berntorp, Erik
Dargaud, Yesim
Gutowski, Zeynep
Negrier, Claude
Pavlova, Anna
Oldenburg, Johannes
BLOOD, 2018, 132
[17] Long-Term Follow-up of Hemophilia a Patients Who Previously Showed Complete or Partial Success in Immune Tolerance Induction Therapy with a Single Plasma-Derived FVIII/VWF Product: Long-Term ITI Study
Jimenez-Yuste, Victor
Oldenburg, Johannes
Rangarajan, Savita
Peiro, Roser
Santagostino, Elena
BLOOD, 2015, 126 (23)
[18] First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study
Kreuz, W.
Ettingshausen, C. Escuriola
Vdovin, V.
Zozulya, N.
Plyushch, O.
Svirin, P.
Andreeva, T.
Bubanska, E.
Campos, M.
Benedik-Dolnicar, M.
Jimenez-Yuste, V.
Kitanovski, L.
Klukowska, A.
Momot, A.
Osmulskaya, N.
Prieto, M.
Salek, S. Z.
Velasco, F.
Pavlova, A.
Oldenburg, J.
Knaub, S.
Jansen, M.
Belyanskaya, L.
Walter, O.
HAEMOPHILIA, 2016, 22 (01) : 87 - 95

← 1 2 →